Sanofi Set To Jump Zika Vaccine Scientific and Regulatory Hurdles

In an interview, Sanofi's global head of research Nicholas Jackson discusses firm's 'jumpstart' and where FDA and WHO should step in.

More from Clinical Trials

More from R&D